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INTRODUCTION
The inflammatory process plays an essential role in all phases of 
atherosclerosis development from initiation to clinical complications. 
This process begins in early childhood and can last throughout life, 
although its intensity changes depending on many factors which 
intensify or mitigate the inflammatory changes [6,19]. Limitation of 
the inflammatory process in the arteries is one of the most important 
strategies for primary prophylactic procedures as well as for secondary 
prevention against atheromatous complications, such as myocardial 
infarction and cerebral stroke [26,28]. 
C-reactive protein (CRP) is a non-specific indicator of the acute 
inflammatory state. It is used for detecting the inflammatory process 
in the course of acute injuries or infections. In the last decades, 
studies have pointed to a positive correlation between high sensitivity 
C-reactive protein (hsCRP) and intensity of the atheromatous process 
and the risk of cardiovascular events occurring as atheromatous 
complications [5,30,33]. Inflammatory markers, among them hsCRP , 
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ABSTRACT:  Atheromatosis develops as a result of a chronic inflammatory process of the arteries. Inflammatory 
biomarkers, particularly high-sensitivity C-reactive protein (hsCRP), positively correlate with atheromatosis risk factors 
and can be used to estimate and predict the risk of cardiovascular events. The purpose of this study was to evaluate 
the relationship between hsCRP concentration and BMI, body composition, classical risk factors for cardiovascular 
diseases, energy expenditure for physical activity (WEE) and  
· VO2max. 166 volunteers (78 women and 88 men) 
were included in the examinations. Their mean age was 20.2±0.9 years. Health condition was described by   
the following variables: smoking, WEE,  
· VO2max, body mass index (BMI), waist-to-hip ratio (WHR), fat mass (FM), 
fat-free mass (FFM), lipid profile, hsCRP, glucose and insulin concentration, and insulin resistance. Between   
the subgroups created on the basis of hsCRP concentration, in quartiles 1 to 3 and quartile 4, a comparative analysis 
was carried out. 79.5% of women and 69.3% of men had hsCRP values within the references ranges. Moderately 
high values were found in 14.1% of women and 22.7% of men and high in 6.4% and 7.9%, respectively. Mean 
values of BMI, FFM, WHR, WEE,  
· VO2max, glucose and triglyceride concentration, and TC/HDL index were significantly 
lower, while FM and HDL were significantly higher, in women than in men. In the quartile 4 subgroup compared 
to the quartile 1-3 subgroup, we found significantly lower HDL concentration and a tendency for higher values of 
BMI (p=0.06) and TC (p=0.07) as well as higher percentages of smoking among men. In young, physically active, 
healthy persons, serum concentration of hsCRP is not related to physical activity or  
· VO2max. 
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seemed to be the most promising and proved useful in predicting 
the activities of inflammatory states and endothelial dysfunctions 
[7,15,25]. C-reactive protein as a mediator of cardiovascular disease 
can effect by decreases endothelial nitric oxide synthase, inducing   
a pro-atherogenic effect and the ability of plaque remodelling [4]. 
While hsCRP concentration below 1 mg · l
-1 is recognized as normal, 
the level between 1 mg · l
-1 and 3 mg · l
-1 is treated as moderately 
increased, which can indicate a slightly increased risk of cardiovascular 
events, whereas numerous researchers have recognized high values 
(hsCRP >3 mg · l
-1) as an indicator increasing risk of cardiovascular 
(CV) events. Persons with diagnosed cardiovascular disease (CVD) 
as well as without clinical symptoms of CVD with hsCRP >3 mg · l
-1 
have a higher risk of CV events than persons with hsCRP below this 
level [4,28,29]. Limitations for using CRP in identifying the occurrence 
and intensity of inflammatory processes arise from the non-specific 
character of this marker as the product of many metabolic and 
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inflammatory processes. Rich sources of inflammatory cytokines 
such as interleukins (IL-6, IL-1) and tumour necrosis factor (TNF-α) 
are abdominal fat cells. The main source of CRP is the liver.   
An increased level of IL-6 [15] is a strong stimulator for the secretion 
of CRP by the liver. Increased concentration of hsCRP strongly 
correlates with abdominal obesity, insulin resistance and, particularly, 
with the metabolic syndrome [12]. Physical activity has a favourable 
impact on traditional risk factors and decreases the risk of CVD. 
Systematic, moderate intensity physical activity may reduce   
the inflammatory process in the arteries as well decreasing the hsCRP 
level [2,13]. The beneficial effect of physical training on hsCRP 
concentration primarily concerns persons with overweight and obesity. 
However, numerous evaluations of the relationship between physical 
capacity changes and hsCRP have not confirmed the existence of 
such a relation [8].
The aim of this work was to evaluate the relationship between 
serum hsCRP concentration and factors determining health conditions, 
such as body mass index, body composition, traditional risk factors 
of cardiovascular diseases, physical activity and aerobic capacity. 
MATERIALS AND METHODS 
The research was conducted among 166 volunteers, students of   
the University of Physical Education in Warsaw (78 women and 88 
men) of mean age 20.2 ± 0.9 years. The subjects were informed 
about the aim and methods of the examinations and were requested 
to abstain from smoking, drinking alcohol and exercising intensively 
24 hours before examinations. The research was approved by   
the Senate Bioethical Committee of the University of Physical 
Education in Warsaw.
Physical activity was measured using the Seven-Day Physical 
Activity Recall (SDPAR) questionnaire and presented as weekly energy 
expenditure for sport and recreation activities. Body mass as well 
thigh and waist and hip circumferences were measured. Body mass 
index (BMI) and waist-to-hip ratio index (WHR) were calculated. 
Body compositions were assessed using the bioelectrical impedance 
method and BC 418 MA equipment (Tanita Co., Japan). Aerobic 
capacity expressed as maximal oxygen uptake ( 
· VO2max) was 
measured during a graded exercise test using a cycle ergometer 
(Ergomedic 874E, Monark, Sweden) and the expired air analyser 
Sensor Medics 2900/2900c (USA) [19] .
Blood was drawn after overnight fasting from the antecubital vein 
under aseptic conditions using disposable needles and syringes into 
plastic tubes containing lithium heparin. To separate plasma, blood 
samples were immediately centrifuged (15 min, 4000 rpm, 4° C) 
and stored at –70° C until analysis. Plasma glucose levels were 
determined using the oxidase method. Plasma triacylglycerols (TG), 
total cholesterol (TC), and HDL-cholesterol (HDL) concentrations 
were assayed colorimetrically. LDL-cholesterol (LDL) level was 
calculated based on Friedewald’s formula. TC/HDL ratio was 
calculated. Analyses were performed using Randox commercial kits 
(Randox Laboratories, United Kingdom). In the serum, hsCRP was 
measured by immunochemiluminescence method using a Siemens 
Diagnostic set. Insulin concentrations were measured with   
the standard radioimmunoassay method with monoclonal antibodies 
against insulin, using BioSource commercial kits (Belgium).   
The insulin resistance index (HOMA-IR) was evaluated by the 
homeostasis assessment model and calculated from insulin and glucose 
concentrations {insulin (μIU · ml
-1) x glucose (mmol · l
-1) ·22.5
-1} [32].
On the basis of individual distribution of hsCRP values, two 
subgroups of women and men were distinguished. The first subgroup 
included persons from quartiles 1-3 (of hsCRP values) (58 women 
and 66 men), whereas the second subgroup consisted of persons 
from quartile 4 (20 women and 21 men). 
The Shapiro-Wilk test was used to determine whether hsCRP was 
normally distributed. To check differences of hsCRP concentration 
between genders, the Mann–Whitney U test was performed. 
Parametric data were analysed using two-way ANOVA with sex and 
hsCRP level as factors. Data are presented as mean ± SD. Statistical 
significance was set at P < 0.05. All calculations were done with 
SPSS version 17 (SPSS Inc., Chicago, IL).
Women (n=78) Men (n=88)
Statistical 
significance Normal Moderate High Normal Moderate High
(n=62) (n=11) (n=5) (n=61) (n=20) (n=7)
hsCRP [mg · l
-1]
0.42 ± 0.19 1.59 ± 0.58 6.48 ± 2.80 0.46 ± 0.20 1.70 ± 0.36 6.44 ± 4.10 n.a.
0.98 ± 1.66 1.22 ± 1.97 p<0.05
TABLE 1. NUMBER OF MEN AND WOMEN WITH NORMAL, MODERATE AND HIGH LEVEL OF hsCRP 
Note: n.a. – not applicable
hsCRP reference range: normal <1.0 mg·l
-1; moderate 1.0-3.0 mg·l
-1; high >3.0 mg·l
-1
hsCRP values [mg·l
-1]
FIG. 1. DISTRIBUTION OF hsCRP VALUES IN WOMEN AND MEN  
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RESULTS 
A frequency histogram of hsCRP concentrations in the studied 
population is shown in figure 1; the distribution is highly skewed. 
Sixty-three women (79.5%) and 61 men (69.3%) had their hsCRP 
concentration within reference limits, 8 (14.1%) and 16 (22.7%) 
respectively had moderately increased values, while 3 (6.4%) 
women men and 6 (7.9%) men had high values. The mean hsCRP 
concentration among men and women, classified in reference ranges, 
is presented in Table 1. One man of significantly increased   
hsCRP (15.3 mg · l
-1), reflecting an active infectious or inflammatory 
process, was excluded from the observation and subsequent   
analysis. 
Due to the small number of subjects in the subgroup with high 
hsCRP values, the comparative analysis was conducted between the 
subgroup composed of quartiles 1 to 3 and quartile 4. Mean values 
of hsCRP in the subgroups comprising quartiles 1-3 and quartile 4, 
among men and women, are summarized in Table 2. The mean 
values of hsCRP in women and men in quartiles 1-3 stayed within 
the normal range while in quartile 4 they were 2.68 ± 2.64 mg · l
-1 
in women and 2.73 ± 1.62 mg · l
-1 in men. The mean concentration 
of hsCRP did not differ between men and women. 
In order to determine the relationship between body composition 
and analysed parameters of physical condition and energy expenditure 
for physical activity in comparative hsCRP subgroups, a two-way 
ANOVA was performed and the results shown in Table 3. The ANOVA 
found a significant main effect (of sex only) for BMI, body composition, 
WHR, WEE and  
· VO2max, but no interaction effects with sex and 
hsCRP level.
Women (n=78) Men (n=87)
#
Statistical
significance 1-3 quartiles 4 quartile 1-3 quartiles 4 quartile
hsCRP (n=58) hsCRP(n=20) hsCRP(n=66) hsCRP(n=21)
hsCRP [mg · l
-1]
0.39 ± 0.15 2.68 ± 2.64 0.52 ± 0.29 2.73 ± 1.62 n.a.
0.98 ± 1.66 1.06 ± 1.26 p=0.73
TABLE 2. MEAN (± STANDARD DEVIATION) hsCRP IN SUBGROUPS 1-3 QUARTILES AND 4 QUARTILES, AMONG MEN AND WOMEN
Note: n.a. – not applicable, 
#one subject was excluded from further analysis due to high concentration of hsCRP , reflecting an active infectious or inflammatory process
Variables
Women Men Statistical significance
1-3 quartiles 4 quartile 1-3 quartiles 4 quartile
Sex hsCRP level hsCRP hsCRP hsCRP hsCRP
(n=58) (n=20) (n=66) (n=21)
BMI 21.12±2.02 21.93±2.95 23.29±2.22 24.09±3.14 p<0.001 p=0.06
FM [%] 22.90±5.03 23.06±4.62 12.21±3.93 13.87±5.65 p<0.001 p=0.28
FFM [%] 77.10±5.03 76.94±4.62 87.79±3.92 86.13±5.65 p<0.001 p=0.28
WHR 0.84±0.06 0.85±0.06 0.89±0.06 0.92±0.05 p<0.001 p=0.20
WEE [kcal · wk
-1] 3542 ±2241 3474±2542 5394±2485 5277±2439 p<0.001 p=0.83
 
·
VO2max [ml · kg
-1 · min
-1] 40.68±4.60 41.63±4.65 47.72±5.97 49.84±6.85 p<0.001 p=0.49
Smoking [%] 10.3% 10% 1.5% 14% p=0.18 -
Note: BMI - body mass index, FM - fat mass, FFM - fat free mass, WHR - whist to hip ratio index, WEE - weekly energy expenditure for sport and recreation physical activity
TABLE 3. BODY COMPOSITION, PHYSICAL ACTIVITY AND AEROBIC CAPACITY IN hsCRP SUBGROUPS AMONG MEN AND WOMEN 
Variables
Women Men Statistical significance
1-3 quartiles 4 quartile 1-3 quartiles 4 quartile
Sex hsCRP level hsCRP hsCRP hsCRP hsCRP
(n=58) (n=20) (n=66) (n=21)
TG [mmol · l
-1] 0.65±0.28 0.73±0.36 0.83±0.38 0.77±0.36 p=0.06 p=0.88
TC [mmol · l
-1] 4.63±0.57 4.37±0.40 4.56±0.73 4.39±0.75 p=0.85 p=0.07
HDL [mmol · l
-1] 1.60±0.31 1.46±0.21 1.45±0.35 1.35±0.40 p<0.05 p<0.05
LDL [mmol · l
-1] 2.73±0.52 2.57±0.46 2.71±0.79 2.54±0.70 p=0.84 p=0.16
TC/HDL 2.98±0.62 3.04±0.45 3.31±0.95 3.47±1.04 p<0.01 p=0.46
Glucose [mmol · l
-1] 4.47±0.45 4.42±0.28 4.78±0.58 4.76±0.49 p<0.001 p=0.68
Insulin [mmol · l
-1] 8.77±2.94 7.91±3.03 7.20±2.95 6.84±1.77 p<0.01 p=0.22
HOMA-IR 1.74±0.58 1.54±0.59 1.57±0.81 1.43±0.43 p=0.26 p=0.17
Note: TG - triglycerides, TC - total cholesterol, HDL - high density cholesterol, LDL - low density cholesterol, TC/HDL - atheromatosis index, HOMA-IR - an index of insulin resistance
TABLE 4. BIOCHEMICAL RISK FACTORS OF ATHEROMATOSIS IN hsCRP SUBGROUPS AMONG MEN AND WOMEN 
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Results of testing parameters of biochemical risk factors of 
atheromatosis in comparative hsCRP subgroups are summarized in 
Table 4. The ANOVA found significant main effects (sex and hsCRP) 
for HDL, and a significant main effect of sex for TC/HDL, glucose 
and insulin. There was no interaction effect of sex and hsCRP level 
for any parameter.
DISCUSSION 
The role of traditional risk factors in pathogenesis and development 
of cardiovascular disease is commonly acknowledged while the 
applicability of inflammatory state biomarkers in estimating the risk 
of cardiovascular incidents remains controversial [28,36].
Numerous studies of the last decade have proved that hsCRP 
when combined with the traditional CVD risk factors can be used as 
a biomarker which correlates with dyslipidaemia, type 2 diabetes or 
obesity, all being traditional risk factors, as well as the level of physical 
activity and cardiorespiratory fitness.
According to Ridker, adding hsCRP to traditional risk allows for 
reclassification of about 30% of moderate-risk patients to either the 
high- or low-risk category [30].
Many studies indicate a strong positive correlation between hsCRP 
and fatness or BMI [14]. A relation is also emphasized between 
increased hsCRP values and insulin resistance and type 2 diabetes 
[35]. Also a relationship was established between regular physical 
activity and a low level of hsCRP . These data, however, have not been 
confirmed in other recent research [24,36]. 
Koenig and co-workers found a strong positive correlation of CRP 
and age, BMI, smoking and diabetes. Individuals who smoked had 
their CRP concentration increased two to three times when compared 
to non-smokers. Obese persons of BMI >30 have been found to have 
CRP concentration twice as high as persons with BMI <25 [17].
In the Jupiter studies [9], statin treatment was applied according 
to the criterion of high hsCRP alone, without high cholesterol 
concentration (hsCRP >2 mg/dl and LDL <130 mg/dl). As a result, 
a hsCRP concentration reduction by 37% was achieved as well as 
reduction of the cardiovascular fatality rate by 47% and total fatality 
by 20%. Statin treatment also lowered the LDL concentration by 
50%. According to the authors, the JUPITER studies confirmed the 
relationship between the likelihood of cardiovascular events and hsCRP 
and LDL levels achieved after the statin treatment.
It was also proved that changes in the life style leading to 
improvement of physical fitness and reduction of adipose tissue/body 
fat may lower hsCRP and reduce the risk of cardiovascular events 
[16,22]. Research [3,10,11] also shows an inverse relationship 
between physical activity, cardiovascular fitness and hsCRP 
concentration.
Other authors, however, did not find relationships between physical 
activity level and hsCRP [27]. Similarly, Kelly and co-workers stated 
[14] that positive changes in BMI, body fat and  
· VO2max achieved 
through aerobic exercise were not followed by significant lowering of 
hsCRP . The authors suggested that intense physical activity probably 
does not considerably affect low (<1 mg · l
-1) and moderately increased 
(1.0-3.0 mg · l
-1) hsCRP values. However, it is not clear whether it 
affects the reduction of high (>3.0 mg · l
-1) hsCRP values. Also, some 
current review studies emphasize that hsCRP is a weak predictor of 
coronary heart disease compared with other markers and clinical 
information [1].
The present study included young healthy persons of relatively 
high physical activity and average or high aerobic fitness. While 
analysing the level of traditional risk factors in the previous study, 
normal mean values of body composition and biochemical indices 
have been found in this group; moreover, only 9% of female subjects 
and 5% of males smoked cigarettes [20].
Significant differences have been found among the indices analysed 
depending on the sex of the subjects. The mean values of BMI, FFM, 
WHR, energy expenditure in recreational as well as sports physical 
activity,  
· VO2max, systolic and diastolic blood pressure, glucose 
concentration, triglycerides (TG) and the TC/HDL index were lower, 
while FM (%), while HDL was significantly higher in women than in 
men.
As only 12 subjects (7 men and 5 women) had high hsCRP values, 
two comparative subgroups were created on the basis of the hsCRP 
value, namely, quartiles 1-3 and quartile 4. The mean hsCRP 
concentration values in those groups did not differ significantly with 
respect to sex, showing a tendency for lower values in women. The 
only significant differences to be found between subgroups from 
quartiles 1-3 and quartile 4 were those of HDL cholesterol concentration, 
which was higher in the quartile 1-3 subgroup. Quartile 4 tended to 
have higher values of BMI (p=0.06) and TC (p=0.07) than the group 
of lower quartiles. Among men from quartile 4 there was also a higher 
percentage of smokers (14% vs. 1.5%). The lack of a strong relationship 
of selected traditional risk factors (biochemical and somatic) with 
hsCRP revealed in this study confirm a need for further investigations 
in this area.
No relationship was found between hsCRP concentration and   
the physical activity or aerobic capacity as expressed by  
· VO2max. 
These findings are in contrast with selected randomized clinical trials. 
Kuo H.-K. et al. [18] found that in adults CRP concentration levels 
are inversely related to cardiorespiratory fitness and could be an 
important indicator of exercise tolerance, and they suggested that 
cardiorespiratory fitness may be one of the mechanistic factors in the 
pathway from chronic inflammation to functional disabilities or CVD. 
McVean J.J. et al. [21] demonstrated a negative correlation between 
CRP concentration and maximum oxygen consumption in non-obese 
children. On the other hand, there are other studies showing no 
association of hsCRP concentration and maximal oxygen uptake, even 
in overweight women [23]. Kelly G.A. et al. [14], in a meta-analysis 
of randomized controlled trials, suggested that aerobic exercise does 
not reduce CRP concentration in adults, but does improve measures 
of body composition and physical fitness, which are known as important 
factors in CVD prevention. In a recent study, Siahkouhian M. and 
Esmaeilzadeh S. [31] reported lack of an association between hsCRP   
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